Celldex Announces Upcoming Oral Presentation on CDX-301 at the American Society for Blood and Marrow Transplantation 2013 BMT Tandem Meetings

[at noodls] – NEEDHAM, Mass., Feb. 11, 2013 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced that Michael Yellin, MD, Vice President of Clinical Science, will present final results from a … more

View todays social media effects on CLDX

View the latest stocks trending across Twitter. Click to view dashboard

See who Celldex is hiring next, click here to view